1. Home
  2. POET vs IRMD Comparison

POET vs IRMD Comparison

Compare POET & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo POET Technologies Inc.

POET

POET Technologies Inc.

SELL

Current Price

$8.08

Market Cap

1.6B

Sector

Technology

ML Signal

SELL

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$86.73

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POET
IRMD
Founded
1972
1992
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
POET
IRMD
Price
$8.08
$86.73
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$116.00
AVG Volume (30 Days)
28.5M
79.3K
Earning Date
05-13-2026
05-01-2026
Dividend Yield
N/A
0.90%
EPS Growth
N/A
16.67
EPS
N/A
1.75
Revenue
N/A
$83,814,000.00
Revenue This Year
$848.96
$12.38
Revenue Next Year
$700.00
$11.31
P/E Ratio
N/A
$50.62
Revenue Growth
N/A
14.43
52 Week Low
$3.79
$50.36
52 Week High
$15.50
$107.90

Technical Indicators

Market Signals
Indicator
POET
IRMD
Relative Strength Index (RSI) 50.17 29.45
Support Level $5.40 $82.64
Resistance Level $9.14 $87.54
Average True Range (ATR) 1.37 3.08
MACD 0.20 -0.49
Stochastic Oscillator 22.69 6.45

Price Performance

Historical Comparison
POET
IRMD

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Share on Social Networks: